Marcus Herdener
PD Dr. med., Head of the Center for Addictive Disorders
Data updated
Research Footprint
Marcus Herdener appears in 7 tracked papers (2017–2026), most studied alongside Placebo, Psilocybin and LSD, across Neuroimaging & Brain Measures, Alcohol Use Disorder (AUD) and Substance Use Disorders (SUD).
Most-cited paper: The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation (399 citations).
Frequent co-authors: Katrin Preller, Franz Vollenweider and Nathalie Rieser.
Background & Research
Marcus Herdener studied medicine at the University of Freiburg and completed specialist training in psychiatry and psychotherapy at the University Hospitals of Basel and Bern and the University of Basel. He later worked as a visiting scientist at the Max-Planck Institute for Biological Cybernetics in Tübingen before joining the Psychiatric Hospital of the University of Zurich, where he leads the Center for Addictive Disorders. His research spans addiction, neurobiology, and psychedelic-assisted therapy.
Key Impact
He is a Swiss psychiatrist and addiction-medicine researcher who appears as a coauthor on multiple influential psychedelic science papers on LSD, psilocybin, and ketamine.
Collaboration Network
10 collaborators· click a node to visit their profile
Full network →